Latest Posts
About This Stock
More About This Stock
Read
Read
Vaccinex Provides Update Of Potentially Pivotal SIGNAL Clinical Trial In Huntington’s Disease
Article By:
TalkMarkets Newswire
Tuesday, July 7, 2020 8:34 AM EDT
Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Article By:
Benzinga
Sunday, June 14, 2020 3:13 PM EDT
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
In this article: MRK, EVOK, RARE, EPZM Also: AZN, GILD, BMY, SNY, RPRX, CELG, PRQR, NBRV, CBIO, UROV, CNTG